Point Mutations of Two Arginine Residues in the Streptomyces R61 Dd-Peptidase by Bourguignon-Bellefroid, Catherine et al.
Biochem. J. (1992) 283, 123-128 (Printed in Great Britain)
Point mutations of two arginine residues in the
Streptomyces R61 DD-peptidase
Catherine BOURGUIGNON-BELLEFROID,* Bernard JORIS,* JozefVAN BEEUMEN,t
Jean-Marie GHUYSEN* and Jean-Marie FRERE*T
*Laboratoire d'Enzymologie et Centre d'Ing6nierie des Proteines, Universite de Liege, Institut de Chimie,
B6, B-4000 Sart-Tilman, Belgium, and tLaboratorium voor Microbiologie en Microbiele Genetica,
Rijksuniversiteit-Gent, Ledeganckstraat 35, B-9000 Gent, Belgium
Incubation of the exocellular DD-carboxypeptidase/transpeptidase of Streptomyces R61 with phenylglyoxal resulted in a
time-dependent decrease in the enzyme activity. This inactivation was demonstrated to be due to modification of the Arg-
99 side chain. In consequence, the role of that residue was investigated by site-directed mutagenesis. Mutation of Arg-99
into leucine appeared to be highly detrimental to enzyme stability, reflecting a determining structural role for this residue.
The conserved Arg-103 residue was also substituted by using site-directed mutagenesis. The modification to a serine
residue yielded a stable enzyme, the catalytic properties of which were similar to those of the wild-type enzyme. Thus Arg-
103, although strictly conserved or replaced by a lysine residue in most of the active-site penicillin-recognizing proteins,
did not appear to fulfil any essential role in either the enzyme activity or structure.
INTRODUCTION
The exocellular DD-carboxypeptidase/transpeptidase of
Streptomyces R61 serves as a model for the membrane-bound
DD-peptidases involved in bacterial cell-wall biosynthesis (Frere
& Joris, 1985). It is inactivated by /?-lactam compounds in a
reaction involving acylation of the Ser-62 residue (Frere et al.,
1976; Joris et al., 1987).
Active-site serine DD-peptidases and /-lactamases form a large
family of penicillin-recognizing proteins, and studies of the
functional role of the active-site residues have until recently been
restricted to the latter enzymes. Although some mutations that
influence penicillin binding or the physiological activity of various
penicillin-binding proteins have been described (Dowson et al.,
1989; Laible et al., 1989; Brannigan et al., 1990; Schuster et al.,
1990; Lujan et al., 1991), no detailed analysis of the kinetic
properties of the mutants has been reported. In the R61 DD-
peptidase, the role of the two tryptophan residues, Trp-233 and
Trp-271, has been probed by chemical modification and site-
directed mutagenesis (Bourguignon-Bellefroid et al., 1992) and
that of His-298 by the latter technique (Hadonou et al., 1992),
but the residues that assist the active Ser-62 residue in catalysis
and in the interaction with fl-lactams remain unknown.
In the present study, we have investigated the importance of
arginine residues in this enzyme. Indeed, it has been generally
assumed that a positively charged group of the enzyme is involved
in charge-pairing with the C-terminal carboxylate of the substrate
or the carboxylate on C-3 ofpenicillins (or C-4 ofcephalosporins).
Such a positively charged group might be important for the
recognition of substrates and inactivators by the DD-peptidases
and the 8-lactamases (Varetto et al., 1987, 1991; Laws & Page,
1989). The first residue of the 'HTG' motif (box VII; Joris et al.,
1988) has been considered as a likely candidate for charge-
pairing (Kelly et al., 1989), but the pH-dependence of both
hydrolysis of the substrates and inactivation by penicillins seems
to indicate the importance of a group of pK close to or larger
than 9 (Varetto et al., 1987). The only phenomenon exhibiting a
strong pH-dependence between 6 and 8 is the transpeptidation
reaction (Frere et al., 1973). The lysine residue of the S*XXK
motif, where S* is the active-site serine, is strictly conserved in all
active-site-serine penicillin-recognizing proteins. Many results
obtained with fl-lactamases indicate that substitutions affecting
this residue result in a very important loss of activity (Madgwick
& Waley, 1987; Tsukamoto et al., 1990), although it does not
seem to be involved in an interaction with the penicillin carboxy-
late (Moews et al., 1990; Herzberg, 1991). Chemical-modification
experiments (Georgopapadakou et al., 1981) have been inter-
preted by assuming that an arginine residue was present in the
active site of the Streptomyces R61 DD-peptidase. However, a
reaction with one or more lysine residues could also explain these
results (Means & Feeney, 1964). The R61 DD-peptidase contains
14 arginine and seven lysine residues (Duez et al., 1987). In the
present investigation we have examined the effect of phenyl-
glyoxal on the enzyme activity and penicillin-binding properties.
An apparently essential arginine residue was identified and its
role further investigated by site-directed mutagenesis. Another
arginine residue, formerly characterized as being conserved in
most penicillin-recognizing enzymes, was also modified by the
latter method.
MATERIALS AND METHODS
Enzymes, chemicals and antiserum
The enzymes used in the recombinant DNA techniques were
from Bethesda Research Laboratory (Gaithersburg, MD,
U.S.A.), New England Biolabs (Beverly, MA, U.S.A.),
Boerhinger (Mannheim, Germany) and Amersham Inter-
national, Amersham, Bucks., U.K. The wild-type R61 enzyme
was produced by the Streptomyces lividans TK24 strain con-
taining plasmid pDMLI 15 (Hadonou et al., 1992) and purified
as described previously (Fossati et al., 1978). The class A ,-
lactamase of Bacillus licheniformis 749/C was purified according
to the method of Matagne et al. (1990).
[y-[35S]Thio]dATP (1350 Ci/mmol) was from NEN (Boston,
MA, U.S.A.), and [7-14C]phenylglyoxal (25 nCi/nmol) and
['4C]benzylpenicillin (54 nCi/nmol) were from Amersham Inter-
national; benzylpenicillin was from Rhone-Poulenc (Paris,
France), ampicillin was from Bristol Benelux (Brussels, Belgium),
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carbenicillin was from Beecham Research Laboratories (Brent-
ford, Middx., U.K.), cefuroxime was from Glaxo Group Re-
search (Greenford, Middx., U.K.) and cefoxitin was from Merck,
Sharp and Dohme (Rahway, NJ, U.S.A.). All the unlabelled /3-
lactams were kindly given by the respective companies. Nitrocefin
was from Oxoid (Basingstoke, Hampshire, U.K.). Phenylglyoxal
and cyclohexane- 1,2-dione were from Janssen Chimica (Beerse,
Belgium); the tripeptide Ac2-L-Lys-D-Ala-D-Ala was from UCB
Bioproducts (Braine-l'Alleud, Belgium). The poor substrate Ac-
L-Ala-D-Glu-Gly was a gift from Dr. H. R. Perkins (University
of Liverpool, Liverpool, U.K.). The thioester substrate
(C6H.-C NH-CH2-C S-CH2<02-)was synthesized in our
laboratory (Adam et al., 1990). Rabbit anti-(R61 DD-peptidase)
serum was from Gamma S. A. (Angleur, Belgium).
Modification procedure
Modification experiments with phenylglyoxal and
cyclohexane- 1,2-dione were carried out in 10 mM-sodium borate
buffer, pH 8, and 20 mM-boric acid, pH 9, respectively. Samples
were withdrawn and diluted at least 40-fold, and the residual
enzymic activity was determined.
Labelling experiments
For the binding of [14C]phenylglyoxal, reaction mixtures
contained 1 mM-['4C]phenylglyoxal (5 nCi/nmol) and 38,ug of
pure enzyme (1 nmol) in a total volume of 25 ,1 of 10 mM-sodium
borate, pH 8. Binding was determined by measuring the amount
of radioactivity associated with the protein after separation from
the excess reagent by t.l.c. (solvent: butanol/water/acetic acid/
ethanol, 10:4: 3: 3, by vol.). Parallel determination of the residual
hydrolytic activity allowed the computation of the number of
inactivator molecules bound per mol of inactivated enzyme.
Another sample was incubated with 5 nmol of benzylpenicillin
before the treatment with phenylglyoxal.
["4C]Benzylpenicillin-binding assays were performed at 37 °C
for 10 min. Assay mixtures containing 38 ,g of pure enzyme
80 %-inactivated by 25 nmol of phenylglyoxal were centrifuged
on Centricon-10 (molecular-mass cut-off 10 kDa) to eliminate
the excess of phenylglyoxal and incubated with 2 nmol of
[I4C]benzylpenicillin (40 /SM, final concentration). The labelled
protein was isolated by t.l.c. before liquid-scintillation counting.
Oligonucleotides
Oligodeoxynucleotides were obtained from Eurogentec (Liege,
Belgium). The crude oligonucleotides were purified by electro-
phoresis on a 20% (w/v) polyacrylamide gel containing 8 M-urea
and desalted by using a spun column (Maniatis et al., 1982). The
oligonucleotides used to introduce the mutations were the
following: R99L, TGCTGCCCGACGACCTGATCACC
GTGCGTC; R103S, TCACCGTGAGTCAGGTGAT.
Strains, plasmids and growth conditions
The Escherichia coli TG1 strain was used as a host for
bacteriophage M13, and the S. lividans TK24 strain (Hopwood
et al., 1985) was used for enzyme expression and production. The
Streptomyces plasmid pIJ702 (Katz et al., 1983) was modified in
order to remove its SphI and PstI sites. Plasmid pDML1 10, as
prepared by Duez et al. (1987), was used as a source of the DD-
peptidase gene. The expression vector was pDML1 15 (Hadonou
et al., 1992). Growth conditions for the expression of the mutant
proteins were as described in Jacob et al. (1990).
DNA recombinant techniques
The procedures used were those described in Maniatis et al.
(1982) and Hopwood et al. (1985). Site-directed mutagenesis was
performed using the 'Oligonucleotide-directed in vitro muta-
genesis' kit from Amersham. Nucleotide sequencing was carried
out by the bacteriophage M 13 dideoxy chain-termination method
using the USB Sequenase kit.
Mutagenesis, expression and purification
These were as described in Bourguignon-Bellefroid et al.
(1992). The concentration of the pure enzymes ( > 90 %) was
determined by u.v.-absorbance measurements by using a molar
absorption coefficient at 280 nm of 38000 M-l cm-'.
Instrumentation
Isoelectric focusing was performed on a Pharmacia Phast
system apparatus in the pH range 3-10. T.l.c. was performed on
Polygram Sil-G plates (Macherey and Nagel, Diiren, Germany).
The solvent was butanol/water/acetic acid/ethanol (10:4:3:3,
by vol). High-voltage electrophoresis was carried out on What-
man 3MM paper for 45 min in pyridine/acetic acid/water
(25:1:225, by vol), pH 6.5, in a Gilson model DW electro-
phorator (60V/cm). Radioactive peptides were localized by
liquid-scintillation counting. The ['4C]phenylglyoxal-labelled
Arg-99-containing peptide was purified on a C,8 reverse-phase
PEP-RPC HR 5/5 chromatography column connected to an
f.p.l.c. system (Pharmacia, Uppsala, Sweden). Solvent A was
0.1 % (v/v) trifluoroacetic acid and solvent B was 70% (v/v)
acetonitrile in 0.1 % (v/v) trifluoroacetic acid. Elution was
performed with a linear gradient (27-40% of solvent B) over
11 ml at a flow rate of 0.5 ml/min. The peptide was sequenced
with the help of an Applied Biosystem gas-phase Sequenator
(Hewick et al., 1981). Amino acid analysis was performed with a
Pico-Tag analyser (Waters, Millipore).
Fractionation of the Streptomyces cells
Three fractions were separated: the 'lysozyme-releasable'
fraction, the membranes and the cytoplasm; fractionation was
performed as described by Leyh-Bouille et al. (1977).
Determination of kinetic parameters
Absorbance measurements were performed with a Uvikon 860
spectrophotometer coupled to a microcomputer via an RS232
interface. Hydrolysis of the tripeptide Ac2-L-Lys-D-Ala-D-Ala
was monitored by estimating the amount of released D-alanine
with the help of the D-amino acid oxidase procedure (Frere et al.,
1976). The kcat./Km values were determined by using first-order
analyses of the time-courses at [S] < Km and on the basis of
Hanes plots. Hydrolysis and aminolysis of the thioester substrate
were monitored spectrophotometrically at 250 nm by using an
absorption coefficient variation value of 2200 M-1 cm-'. Separate
values for kcat and Km were computed from complete time
courses as described by De Meester et al. (1987).
Inactivation experiments were performed by mixing enzyme,
reporter thioester substrate and inactivator and analysing the
time course of thioester hydrolysis as described in De Meester
et al. (1987). The deacylation rate constant (k3) was determined
as described in Frere et al. (1974): after complete inactivation of
the enzyme and elimination of the excess of free ,3-lactam by
addition of a small amount of the Enterobacter cloacae P99
/,-lactamase, recovery of the enzyme activity was monitored with
the tripeptide Ac2-L-Lys-D-Ala-D-Ala.
All incubations were performed at 37 °C in 10 mM-sodium
phosphate buffer, pH 7.
RESULTS
Inactivation by phenylglyoxal
Incubation of the DD-peptidase with phenylglyoxal resulted in
progressive loss of the enzyme hydrolytic activity as assayed on
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Fig. 1. Inactivation of the R61 enzyme by phenylgly
1,2-dione
Residual hydrolytic activity after incubation of
with (a) phenylglyoxal at the concentrations in
10 mM-sodium borate buffer, pH 8 and (b) cyclo
the concentrations indicated at 30 °C in 20 m!
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Fig. 3. Protection of the R61 enzyme against phenylglyoxal inactivation by
the Ac-L-Ala-D-Glu-Gly peptide
All incubations were carried out at 37 'C. The R61 enzyme was
preincubated with the 20 mM-peptide for 15 min before 0.5 mM-
phenylglyoxal was added. Curve 1, R61 + peptide; curve 2, R61 +
peptide + phenylglyoxal; curve 3, R61 + phenylglyoxal. Activities
are expressed as in Fig. 1.
2 by a 17 h incubation at 37 'C. Inactivation rate increased with
increasing pH, control activity remaining virtually unchanged in
60 80 the pH range examined (7.0-9.0) (Fig. 2, curve a).
When the enzyme was inactivated by a 10-fold stoichiometric
oxal and cyclohexane- excess of benzylpenicillin before phenylglyoxal treatment, a
complete recovery of the enzyme activity was observed after
the enzyme (25,UM) addition of the ,-lactamase and dilution. The decay of the
idicated at 37 'C in inactive acyl-enzyme occurred with a half-life similar to that
,hexane- 1,2-dione at recorded in the absence of phenylglyoxal treatment. In conditions
m-boric acid, pH 9u similar to those of Fig. 1(a), the activity loss caused by 2 mM-
~tof an unmodified phenylglyoxal decreased from 80 to 400% in 60 min when the
experiment was performed in the presence of 20 mM-Ac-L-Ala-D-
Glu-Gly, a very poor substrate for which a Ki value of about
15 mm was measured by competition with the usual substrate
Ac2-L-Lys-D-Ala-D-Ala (Fig. 3). Protection against inactivation
was thus afforded if benzylpenicillin or the poor substrate Ac-L-
Ala-D-Glu-Gly occupied the enzyme active site, suggesting the
presence of a reactive arginine or lysine residue in the active site.
['4C]Benzylpenicillin binding was also inhibited by phenylglyoxal.
After a 10 min incubation with [14C]benzylpenicillin, the
>\b phenylglyoxal-treated 80 %-inactivated enzyme was found to
bind only 54% of the labelled benzylpenicillin bound by the
a ; same amount of intact enzyme. This showed that the rate of
binding of penicillin to the modified enzyme was drastically
decreased, since, with the intact enzyme, the same level of
8.5 labelling should be reached in about 1 s.
*.5 9 Similar inactivation time courses (Fig. lb), pH-dependence
(Fig. 2, curve b) and protection by benzylpenicillin (results not
d and cyclohexane-1,2- shown) were also obtained with cyclohexane-1,2-dione.
dione
Residual hydrolytic activity after a 60 min incubation of the R61
enzyme (25 #M) with (curve a) 0.5 mM-phenylglyoxal at 37 °C and
(curve b) 2 mM-cyclohexane- 1,2-dione at 30 °C at the pH values
indicated. Activities are expressed as in Fig. 1. The following buffers
were used: pH 7.0 and 7.5, 50 mM-sodium phosphate; pH 8.0,
10 mM-sodium borate; pH 8.5, 10 mM-Hepes+25-,uM EDTA;
pH 9.0, 20 mM-boric acid.
the synthetic tripeptide Ac2-L-Lys-D-Ala-D-Ala. The time-course
of inactivation by four concentrations of phenylglyoxal is shown
in Fig. l(a). Inactivation was not reversed by overnight dialysis
(4 °C) against 10 mM-potassium phosphate buffer, pH 7, followed
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Stoichiometry of inactivation of the DD-peptidase by
phenylglyoxal
Incubation of 1 nmol of enzyme with 25 nmol of
[14C]phenylglyoxal for 20 min (residual hydrolytic activity about
20 %) followed by t.l.c. resulted in incorporation of radioactivity
into the protein peak corresponding to 3.4 + 0.34 nmol of
['4C]phenylglyoxal/nmol of inactivated enzyme. If the modifi-
cation reaction was performed when the active site was protected
by benzylpenicillin, only 2.5 + 0.5 nmol of [14C[phenylglyoxal
was incorporated per nmol of enzyme. This indicated that several
enzyme residues were modified and confirmed that the presence
of the penicilloyl residue in the active site apparently prevented
the modification of one of them.
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Table 1. Separation of the I14Clphenylglyoxal-labeiled peptides by high-voltage electrophoresis at pH 6.5
Mobilities are relative to lysine = + 1.00 (+ and - indicate migration towards cathode and anode respectively). The radioactivity found in the
various peptides essentially accounted for that present in the initial sample before proteolytic digestion (about 100 %). Abbreviation: PenG,
benzylpenicillin.
R61 + [14C]phenylglyoxal R61 + PenG + ['4C]phenylglyoxal
Mobility














































Identification of the amino acid residue involved in the
inactivation reaction
The enzyme was inactivated to 80% by [14C]phenylglyoxal
and the complex thus formed was filtered on Sephadex G-25 in
50 mM-NH4HCO3 and freeze-dried. The labelled enzyme was
digested with pepsin [2% (w/w) with respect to the DD-peptidase]
in 5 % (v/v) formic acid at 37 °C for 4 h and then with trypsin
[2% (w/w)] in 25 mM-NH4HCO3at 37 °C for 4 h. The digest was
then submitted to electrophoresis at pH 6.5, giving seven radio-
active peaks (Table 1). The radioactivity of peak 4 decreased
when the enzyme was protected by benzylpenicillin before
reaction with phenylglyoxal suggesting that it contained the
active-site' peptide. Peptide 4 was eluted from the electro-
phoretogram with 1% (v/v) formic acid and purified by three
successive identical chromatographies on the reverse-phase
column. Its amino acid sequence was determined and
corresponded to that of the Thr-89-Arg-99 segment of the
DD-peptidase (Thr89-Tyr-Leu-Pro-Gly-Leu-Leu-Pro-Asp-Asp-
Arg99). In parallel to this, a similar analysis of Pronase digests
[Pronase (10%, w/w) in 10 mM-phosphate buffer, pH 7, for 2 h
at 37 °C] of the modified and subsequently heat-denatured DD-
peptidase was performed. The 'active-site' labelled protein
fragment isolated under those conditions contained only an
arginine residue, as revealed by amino acid analysis. These
results indicated that Arg-99 was the residue involved in the
inactivation reaction by phenylglyoxal. Its role, together with
that of the conserved Arg-103 residue, was further investigated
by site-directed mutagenesis: Arg-99 was replaced by leucine and
Arg-103 by serine.
Production of the mutant DD-peptidases
The leucine and serine residues were chosen to replace the
arginine residues in order to eliminate the positive charge
associated with the arginine side chain.
After mutagenesis and sequencing, the PstI-SphI fragments
(0.5 kb) coding for the N-terminal part of the mutant DD-
peptidases were cloned into the previously described Strepto-
myces plasmid (Hadonou et al., 1992) to replace the equivalent
wild-type fragment. After transformation of the S. lividans TK24
protoplasts, the recombinant plasmids pDML22 (R103S) and
pDML32 (R99L) were purified, and the DNA fragments coding
for the DD-peptidases were released by restriction, recloned into
bacteriophage M13 and resequenced in the region of the mu-
tation. This procedure was designed to avoid the occurrence of
a wild-type gene in the plasmid preparations. The presence of the
mutations in pDML22 and pDML32 was thus confirmed. Mutant
DD-peptidases were then produced in 5-litre 7-day cultures and
purified as described by Bourguignon-Bellefroid et al. (1992).
The R103S enzyme preparation was more than 90% pure as
estimated by SDS/PAGE.
R99L mutant DD-peptidase
No enzymic activity was detected in the culture supernatant.
Attempts to detect an inactive protein were made by using
SDS/PAGE, with the wild-type enzyme as an Mr standard,
followed by Western blotting for immunological localization. All
these tests remained negative. Cells were then fractionated and
all fractions submitted to SDS/PAGE and Western blotting.
Only a very weak response was obtained in the 'Iysozyme-
releasable', membrane and cytoplasmic fractions, corresponding
to a production lower than 0.05 mg of recombinant protein/I of
culture. No hydrolytic activity could be detected with the good
substrate Ac2-L-Lys-D-Ala-D-Ala, which showed that the
immunological method detected a protein with less than 0.1 %
activity of the wild-type. It thus appeared that the enzyme was
either underexpressed or that its rate of folding was significantly
decreased, resulting in a much faster proteolysis of the nascent
protein, and that its secretion was also impaired. This under-
expression could not be attributed to the choice of an infrequent
codon for leucine, since CTG is the most often used in the
Streptomyces R61 DD-peptidase gene (Duez et al., 1987). The
modified enzyme could not be produced and purified.
R103S mutant DD-peptidase
The mutation R103S yielded an enzyme the stability of which
at 37 °C did not differ significantly from that of the wild-type
(inactivation ti > 1500 min for both enzymes).
Isoelectrofocusing revealed the presence of two bands for both
wild-type and mutant enzyme preparations, which, however,
behaved homogeneously on SDS/PAGE. The pI values were 4.2
and 4.5 for the wild-type and 4.1 and 4.4 for the R103S enzymes,
thus confirming the more acidic character of the mutant. For the
wild-type enzyme, the two forms have been separated by ion-
exchange chromatography and exhibit identical enzymic and
penicillin-binding properties (M. Jamin & J.-M. Frere, unpub-
lished work). The structural basis for the presence of two active
protein variants is presently under investigation. It is interesting
to note that such a phenomenon had not been previously observed
when the enzyme was produced by the R61 strain itself (Frere
et al., 1973).
The catalytic properties of the mutant DD-peptidase with the
1992
126
Mutations of arginine residues in Streptomyces R61 DD-peptidase
Table 2. Kinetic parameters for the interaction of the wild-type and R103S
enzymes with substrates and AOilactams
The kinetic parameters for the hydrolytic + transpeptidase activity
were determined in the presence of 290 1sM-thioester substrate and




kcat /Km (M1s-1) 3900* 2250
Esterase activity (thioester)
kcat (s-1 5 +0.3 5.3 +0.6
Km (/M) 41 +4 49.5 +4
kcat./Km (M-1* S-1) 120000+19000 107000+20000
Esterase + transpeptidase activity (thioester-D-Ala)
kcat. (s-') 47+13 32.5 +4.5
Km (aM) 308 +60 385 + 60
kcat./Km (M-1 S-1) 153000+70000 84000+24000
Interaction with /-lactamst
Benzylpenicillin k2/K 14000 14170
k3 1.4x 10-4* 1.1 x 10-4
Carbenicillin k2/K 830* 600
k3 1.4 x 10-4* 1.3 x 105
Ampicillin k2/K 110* 100
k3 1.4 x 10-4* 0.9 X 10-4
Nitrocefin k2/K 4100 4140
k3 3 x 10-4* 2 x 10-4
Cefuroxime k2/K 1400 520
k3 4x10-6* 5.3x10-6
Cefoxitin k2/K 1500* 20100
k3 5x 10-5* 8.3x 10-6
* From Frere & Joris (1985).
t k2/K and k3 values are in M-1 s-' and s-' respectively.
tripeptide and thioester substrates were not drastically affected
(Table 2). The transpeptidation/hydrolysis ratio determined by
h.p.l.c. (Jamin et al., 1991) after incubation of the enzymes with
290 1sM-thioester substrate and 20 mM-D-alanine as acceptor was
the same (8.5) for the wild-type and R103S enzymes. The R103S
enzyme lost 98 % of its hydrolytic activity after a 60 min
treatment with 2 mM-phenylglyoxal. Re-activation of the enzyme
was observed after elimination of the excess reagent if the active
site was protected by benzylpenicillin before treatment with
phenylglyoxal.
The characteristic parameters of the interaction of the mutant
with /3-lactam antibiotics also appeared to be similar to those of
the wild-type enzyme with the striking exception of cefoxitin,
which inactivated the mutant 10-fold faster than the wild-type
enzyme (Table 2).
DISCUSSION
Modification of the R61 DD-peptidase by phenylglyoxal resul-
ted in inactivation time courses similar to those obtained by
Georgopapadakou et al. (1981); however, our results indicated
that more than one enzyme residue was modified. Protection
against inactivation was afforded by benzylpenicillin and the
poor substrate Ac-L-Ala-D-Glu-Gly, suggesting the presence of a
reactive arginine (or lysine) residue in the active site. Arg-99 was
identified as the protected residue involved in the inactivation
reaction and its role was further investigated by site-directed
mutagenesis.
The R99L mutant protein was apparently underexpressed,
segregated inside the cell and inactive. Such low-level expression
of unstable mutant proteins has been reported in the case of the
D131G mutant /3-lactamase of Streptomyces albus G, where the
conserved 'SDN' motif was modified (Jacob et al., 1990), and in
other instances (Schultz & Richards, 1986). Another totally
inactive mutant R61 DD-peptidase (S62C) was expressed in
normal amounts in the culture supernatant, and its folding
appeared to be grossly correct (B. Joris & J.-M. Frere, un-
published work). The R99L mutation thus appeared to be highly
detrimental to enzyme stability, reflecting a determining struc-
tural role for this residue. Yet, Arg-99 is not conserved among
the active-site-serine penicillin-recognizing proteins, and /3-
lactamases even appeared to exhibit a deletion encompassing this
position (Joris et al., 1988). According to the available X-ray
data, Arg-99 lies in the a-domain, outside the active site (Kelly
et al., 1989), and is involved in hydrogen bonds with the chain
bearing the conserved 'YSN' motif (J. Lamotte-Brasseur, per-
sonal communication). The complete elimination of the side
chain can be expected to induce some 'floppiness' of the 'YSN'
loop.
Residue Arg- 103 (box IV; Joris et al., 1988) is strictly conserved
or replaced by a lysine residue in most of the active-site-serine
penicillin-recognizing proteins. Surprisingly, the modification to
a serine residue yielded a stable enzyme, the catalytic properties
of which were similar to those of the wild-type enzyme. Thus a
positive charge at that level did not appear to be essential for the
enzyme activity or structure. A totally unexpected result was the
significant increase in the sensitivity of the mutant to one
particular 3-lactam, cefoxitin. Interpretation of this observation
must await the refinement of the three-dimensional structure and
the modelling of the interaction of the wild-type and mutant
enzymes with various inactivating ,-lactams.
From these results, it appeared that the important residue in
this region of the R61 DD-peptidase primary structure was Arg-
99 instead of Arg- 103. In the analogous class A /8-lactamases, a
conserved lysine residue is found 40 residues after the active
serine residue (Ambler et al., 1991), forming box IV in the
nomenclature of Joris et al. (1988). In the Streptomyces R61 DD-
peptidase, Arg-99 and Arg-103 occur respectively 37 and 41
residues after the active-site serine residue. Our results suggest
that Arg-99 is more likely to be an important residue in a
structurally important conserved box. Finally, the present study
also showed that protection afforded by inhibitors or substrates
against modification by chemical reagents is not indisputable
evidence for the presence of the target amino acid in the active
site.
This work was supported, in part, by an Action Concertee with the
Belgian Government (Convention 86/91-90), the Fonds de la Recherche
Scientifique Medicale (Contract n° 3.4537.88), a Convention Tripartite
between the Region Wallone, SmithKline Beecham, U.K., and the
University of Liege, and the Belgian National incentive programme on
fundamental research in Life Sciences (Contract BIO 22). This text
presents research results of the Belgian programme on Interuniversity
Poles of Attraction initiated by the Belgian State, Prime Minister's Office,
Science Policy Programming. The scientific responsibility is assumed by
its authors. B. J. is Chercheur Qualifie of the F.N.R.S. (Brussels,
Belgium), C. B. B. performed a large part of the work described here as
fellow of the I.R.S.I.A. (Brussels, Belgium).
REFERENCES
Adam, M., Dazmblon, C., Plaitin, B., Christiaens, L. & Frkre, J.-M.
(1990) Biochem. J. 270, 525-529
Ambler, R. P., Coulson, A. F. W., Frere, J.-M., Ghuysen, J.-M., Joris,
B., Forsman, M., Levesque, R. C., Tiraby, G. & Waley, S. G. (1991)
Biochem. J. 276, 269-272
Vol. 283
127
C. Bourguignon-Bellefroid and others
Bourguignon-Bellefroid, C., Wilkin, J. M., Joris, B., Aplin, R. T.,
Houssier, C., Prendergast, F. G., Van Beeumen, J., Ghuysen, J.-M. &
Frere, J.-M. (1992) Biochem. J. 282, 361-367
Brannigan, J. A., Tirodimos, I. A., Zhang, Q. Y., Dowson, C. G. &
Spratt, B. G. (1990) Mol. Microbiol. 4, 913-919
De Meester, F., Joris, B., Reckinger, G., Bellefroid-Bourguignon, C. &
Frere, J.-M. (1987) Biochem. Pharmacol. 36, 2396-2403
Dowson, C. G., Hutchison, A. & Spratt, B. G. (1989) Mol. Microbiol. 3,
95-102
Duez, C., Fraipont, C., Joris, B., Dusart, J., Urdea, M. S., Martial, J. A.,
Frere, J.-M. & Ghuysen, J.-M. (1987) Eur. J. Biochem. 162, 509-518
Fossati, P., Saint-Ghislain, M., Sicard, P. J., Frere, J.-M., Dusart, J.,
Klein, D. & Ghuysen, J.-M. (1978) Biotechnol. Bioeng. 20, 577-587
Frere, J.-M. & Joris, B. (1985) CRC Crit. Rev. Microbiol. 11, 299-396
Frere, J.-M., Ghuysen, J. M., Perkins, H. R. & Nieto, M. (1973) Biochem.
J. 135, 483-492
Frere, J.-M., Leyh-Bouille, M., Ghuysen, J. M. & Perkins, H. R. (1974)
Eur. J. Biochem. 50, 203-214
Frere, J.-M., Duez, C., Ghuysen, J.-M. & Vandekerkhove, J. (1976)
FEBS Lett. 70, 257-260
Georgopapadakou, N. H., Liu, F. Y., Ryono, D. E., Neubeck, R. &
Ondetti, M. A. (1981) Eur. J. Biochem. 115, 53-57
Hadonou, A. M., Jamin, M., Adam, M., Joris, B., Dusart, J., Ghuysen,
J.-M. & Frere, J.-M. (1992) Biochem. J. 282, 495-500
Herzberg, 0. (1991) J. Mol. Biol. 217, 701-719
Hewick, R. M., Hunkapiller, M. W., Hood, L. E. & Dreyer, W. J. (1981)
J. Biol. Chem. 256, 7990-7997
Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Brutton, C. J.,
Kieser, H. M., Lydiate, D. J., Smith, C. P., Ward, J. M. & Schrempf,
H. (1985) Genetic Manipulation of Streptomyces -A Laboratory
Manual, John Innes Foundation, Norwich
Jacob, F., Joris, B., Lepage, S., Dusart, J. & Frere, J.-M. (1990) Biochem.
J. 271, 399-406
Jamin, M., Adam, M., Damblon, C., Christiaens, L. & Frere, J.-M.
(1991) Biochem. J. 280, 499-506
Joris, B., Jacques, Ph., Frere, J.-M., Ghuysen, J.-M. & Van Beeumen, J.
(1987) Eur. J. Biochem. 162, 519-524
Joris, B., Ghuysen, J.-M., Dive, G., Renard, A., Dideberg, O., Charlier,
P., Frere, J.-M., Kelly, J. A., Boyington, J. C., Moews, P. C. & Knox,
J. R. (1988) Biochem. J. 250, 313-324
Katz, E., Thompson, C. J. & Hopwood, D. A. (1983) J. Gen. Microbiol.
129, 2703-2714
Kelly, J. A., Knox, J. R. & Zhao, H. (1989) J. Mol. Biol. 209, 281-295
Laible, G., Hakenbeck, R., Sicard, M. A., Joris, B. & Ghuysen, J.-M.
(1989) Mol. Microbiol. 3, 1337-1348
Laws, A. P. & Page, M. I. (1989) J. Chem. Soc. Perkin Trans. 2 1577-1581
Leyh-Bouille, M., Dusart, J., Nguyen-Disteche, M., Ghuysen, J.-M.,
Reynolds, P. E. & Perkins, H. R. (1977) Eur. J. Biochem. 81, 19-28
Lujan, R., Zhang, Q. Y., Saez Nieto, J. A., Jones, D. M. & Spratt, B. G.
(1991) Antimicrob. Ag. Chemother. 35, 300-304
Madgwick, P. J. & Waley, S. G. (1987) Biochem. J. 248, 657-662
Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982) Molecular Cloning:
A Laboratory Manual, Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY
Matagne, A., Misselyn-Bauduin, A. M., Joris, B., Erpicum, T., Granier,
B. & Frere, J.-M. (1990) Biochem. J. 265, 131-146
Means, G. E. & Feeney, R. E. (1964) Chemical Modification of Proteins,
p. 197, Holden-Day, San Francisco
Moews, P. C., Knox, J. R., Dideberg, O., Charlier, P. & Frere, J.-M.
(1990) Proteins 7, 156-171
Schultz, S. C. & Richards, J. H. (1986) Proc. Natl. Acad. Sci. U.S.A. 83,
1588-1592
Schuster, C., Dobrinski, B. & Hakenbeck, R. (1990) J. Bacteriol. 172,
6499-6505
Tsukamoto, K., Tachibana, K., Yamazaki, N., Ishii, Y., Ujiie, K.,
Nishida, N. & Sawai, T. (1990) Eur. J. Biochem. 188, 15-22
Varetto, L., Frere, J.-M. & Ghuysen, J.-M. (1987) FEBS Lett. 225,
218-222
Varetto, L., De Meester, F., Monnaie, D., Marchand-Brynaert, J., Dive,
G. & Frere, J.-M. (1991) Biochem. J. 278, 801-807
Received 22 July 1991/13 September 1991; accepted 4 October 1991
1992
128
